Title: John R Cardinal: Innovator in Extended-Release Pharmaceutical Formulations
Introduction
John R Cardinal is an accomplished inventor based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in the development of extended-release formulations. His innovative approach aims to enhance the effectiveness of drug delivery systems.
Latest Patents
Although John R Cardinal currently holds no patents, his work on extended-release pharmaceutical formulations showcases his expertise. The formulation he developed includes a matrix-forming, sustained-release system that comprises four primary components. These components are: i) an effective amount of at least one drug substance; ii) at least one pharmaceutically acceptable, water-swellable, pH independent polymer; iii) at least one pharmaceutically acceptable, anionic, pH dependent polymer; and iv) a pharmaceutically acceptable polymer selected from the group consisting of a) at least one pharmaceutically acceptable cationic polymer; and b) at least one pharmaceutically acceptable hydrocolloid. This formulation can be utilized with compounds that have a wide range of solubilities, including those characterized as hydrophobic or hydrophilic.
Career Highlights
John R Cardinal is currently employed at Aaipharma Services Corporation, where he continues to advance his research in pharmaceutical formulations. His work is pivotal in developing innovative solutions that improve patient outcomes through effective drug delivery.
Collaborations
John collaborates with notable colleagues, including Jack Lawrence James and Elsie Melsopp. Their combined expertise contributes to the advancement of pharmaceutical technologies.
Conclusion
John R Cardinal is a dedicated inventor whose work in extended-release pharmaceutical formulations has the potential to significantly impact the field of medicine. His innovative contributions reflect a commitment to improving drug delivery systems for better patient care.